Ambulanc (Shenzhen) Tech. Co., Ltd was established in 2001 by a group of experts in emergency care. Our brand Amoul® is dedicated to innovation and the development of comprehensive life support solutions, and manufacturing respiratory therapy, cardiopulmonary resuscitation (CPR), anesthesia, emergency care, and critical care devices.
The professional R&D team plays a pivotal role in advancing technologies for pneumatic and turbine life support ventilation, CPR, airway management, conscious sedation devices, and anesthesia machines, serving healthcare professionals and patients globally.
Ambulanc owns 1000+ patents and CFDA medical device registration certificates for Class II and Class III medical equipment, besides a wide range of international certifications such as ISO13485, FDA (EUA), CE, MDL, TAG, etc. Our products are distributed across 100+ countries and regions worldwide.
-
2001SINCE
-
700+EMPLOYEES
-
20000+VALUED CUSTOMERS
-
03Amoul® Shines at the 93rd CMEF 2026: Building a Full-Scenario Healthcare EcosystemCMEF 2026 was a remarkable event for Amoul®! Our new product launches showcased innovation and stole the spotlight. Attendees engaged in hands-on CPR training sessions, while exclusive interviews shared insights into our vision. The connections made with global partners were inspiring. Join us as we recap the unforgettable highlights of CMEF 2026!news More
English
中文
Pусский
Español
عربى
Français
Português
Deutsch






